Delivery Order SPE2DB25D9305-SPE2DB25FQAHF
- Not listed
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. The company has been registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device, with a period of performance through January 10, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,552.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order falls under a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The delivery order is for the provision of Mirena 52 mg systems, a...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a contraceptive product, with a completion date of June 17, 2024. This award is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB25FQAHFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure comprehensive pharmaceutical products and medical supplies for military healthcare facilities. DMS Pharmaceutical Group Inc. has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering an extensive range of medical products from prescription medications to biologics and specialty pharmaceuticals. The company's registration in SAM.gov since 2001 and consistent award history demonstrate its reliable capacity to support Department of Defense healthcare operations nationwide. This particular delivery order for Mirena contraceptive systems reflects the company's role in supplying contraceptive devices and other specialized pharmaceutical products to military health facilities as part of DLA's broader medical supply distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/25/25 |